83
Participants
Start Date
July 18, 2017
Primary Completion Date
February 18, 2019
Study Completion Date
February 18, 2019
Placebo
Tablet
BI 1358894
Tablet
BI 1358894 (Test)
Fasting state
BI 1358894 (Reference)
Fed state
CRS Clinical Research Services Mannheim GmbH, Mannheim
Lead Sponsor
Boehringer Ingelheim
INDUSTRY